Skip to main content

Antidepressant Pregnancy Risk: Experts Debate The Risks

2 min read

By Jim Greene

A new study suggests that  depressed pregnant women might not want to risk taking antidepressants while with child. The result of the study is controversial and has the medical community divided.

The study authors Alice Domar and Adam Urato came to a number of conclusions with the study. Urato says that “There’s a clear and concerning evidence of risk with the use of these medications by pregnant women.” Domar continues by saying that antidepressants are only as effective as cognitive behavioral therapy. They continue by saying that antidepressants are linked to miscarriage, premature birth, heart defects, and behavioral development problems.

It would be impossible to properly test their theories. That would require a study where some pregnant women would be given antidepressants such as Prozac, Paxil, Lexapro, Celexa, and Zoloft. If their theories were correct, then the children born could have devastating health effects. That would be at the very least ethically questionable.

Antidepressant drug companies have declined to comment on the study. Other experts in the field have said that the study may be questionable. Gregory Moore, the director of health services at Georgia Tech in Atlanta, commented on the report. “I would say the authors of this article went overboard in terms of their negativity. Depression can be a fatal disease.”

Shari Lesskin, an adjunct associate professor of psychiatry, obstetrics, gynecology and reproductive science at Mount Sinai School or Medicine say that women should consult with their doctor to decide on what course of action they should make.

Source: USA Today

Jim Greene

Contributor

Jim has spent the last 5 years writing for a variety of health-related websites. At Activebeat, James is an essential member of the editorial team, providing information on exercise, diet & nutrition and men’s health – among many other things.

Women

Explore

Endometriosis: It’s Time To Change the Pattern of Pain, Stigma and Barriers to Diagnosis And Treatment
By Sarah Seabrook and Alana Cattapan Women

Endometriosis: It’s Time To Change the Pattern of Pain, Stigma and Barriers to Diagnosis And Treatment

Endometriosis is a debilitating disease that affects an estimated one million Canadians. It involves the overgrowth of endometrial tissue (the tissue that lines the uterus), which typically sheds during menstruation and regrows to support reproduction. With endometriosis, the endometrial tissue grows excessively, both inside and outside of the uterus, which can cause pelvic pain, extreme […]

Read More about Endometriosis: It’s Time To Change the Pattern of Pain, Stigma and Barriers to Diagnosis And Treatment

4 min read

New Treatment for Postpartum Depression Offers Hope, but the Stigma Attached to the Condition Still Lingers
By Nicole Lynch and Shannon Pickett Women

New Treatment for Postpartum Depression Offers Hope, but the Stigma Attached to the Condition Still Lingers

Postpartum depression can affect anyone, and it often sneaks in quietly, like a shadow in the corners of a new mother’s life. It presents significant challenges for around 1 in 7 new mothers, affecting their emotional well-being and overall quality of life and that of the newborn. Many – if not most – women experience […]

Read More about New Treatment for Postpartum Depression Offers Hope, but the Stigma Attached to the Condition Still Lingers

6 min read